Anthony S. Marucci - 17 Jun 2021 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
President & CEO, Director
Signature
/s/ Samuel B. Martin, attorney in fact for Anthony S. Marucci
Issuer symbol
CLDX
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 16:26:23 UTC
Next filing
09 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (right to buy) Award $0 +224,000 $0.000000 224,000 17 Jun 2021 Common Stock 224,000 $28.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
F2 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.